Between 2012 and 2014, a cohort of 90 COPD subjects of disease severity grades GOLD I-IV as well as 60 healthy control subjects (30 smokers and 30 non-smokers) have been examined regarding different clinical and blood/ sputum derived biomarkers at the investigators' research center. This observation study will follow-up/re-examine all available subjects regarding disease course and treatment changes after 3 years (+/-6 months) for the investigation of ncRNA/ transcriptome biomarkers for their potential to indicate disease progression. In addition, biobanking of respective biosamples for potential future COPD biomarker research will be conducted.
Study Type
OBSERVATIONAL
Enrollment
116
Fraunhofer-Institute for Toxicology and Experimental Medicine
Hanover, Germany
Lung volumes by pulmonary function testing
forced expiratory volume in 1 second
Time frame: after 3 years ± 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.